We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Cerebral Ventricular Enlargement and Dopamine Synthesis Inhibition in Chronic Schizophrenia

Henry A. Nasrallah, MD; Joel E. Kleinman, MD, PhD; Daniel R. Weinberger, MD; J. Christian Gillin, MD; Richard Jed Wyatt, MD
Arch Gen Psychiatry. 1980;37(12):1427. doi:10.1001/archpsyc.1980.01780250113018.
Text Size: A A A
Published online


To the Editor.—  The Archives has published a series of studies by Weinberger et al related to lateral cerebral ventricular enlargement and apparent atrophic brain changes on computerized tomographic (CT) scans in over 50% of patients with chronic schizophrenia.1-3 In their January 1980 Archives article,3 Weinberger et al report the finding of poor response to neuroleptic treatment in chronic schizophrenic patients with ventricular enlargement compared with a matched control group of chronic schizophrenic patients who have normal ventricular size. Insofar as neuroleptics are dopamine (DA) receptor blockers, the poor response to these drugs in schizophrenic patients with ventricular enlargement suggests that the DA hypothesis may not be applicable to this group of schizophrenic patients.In light of this finding, we have reexamined the results of two earlier studies that failed to show a neuroleptic-potentiating effect in chronic schizophrenia of α-methyl-p-tyrosine (metyrosine), a dopamine synthesis inhibitor.4.5


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.